Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques

Hongzhao Li, Yan Hai, So Yon Lim, Nikki Toledo, Jose Crecente-Campo, Dane Schalk, Lin Li, Robert W. Omange, Tamara G. Dacoba, Lewis R. Liu, Mohammad Abul Kashem, Yanmin Wan, Binhua Liang, Qingsheng Li, Eva Rakasz, Nancy Schultz-Darken, Maria J. Alonso, Francis A. Plummer, James B. Whitney, Ma Luo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

HIV mutates rapidly and infects CD4+ T cells, especially when they are activated. A vaccine targeting conserved, essential viral elements while limiting CD4+ T cell activation could be effective. Learning from natural immunity observed in a group of highly HIV-1 exposed seronegative Kenyan female sex workers, we are testing a novel candidate HIV vaccine targeting the 12 viral protease cleavage sites (PCSs) (the PCS vaccine), in comparison with a vaccine targeting full-length Gag and Env (the Gag/Env vaccine) in a Mauritian cynomolgus macaque/SIV model. In this study we evaluated these vaccines for induction of mucosal antibodies to SIV immunogens at the female genital tract. Bio-Plex and Western blot analyses of cervicovaginal lavage samples showed that both the PCS and Gag/Env vaccines can elicit mucosal IgG antibody responses to SIV immunogens. Significantly higher increase of anti-PCS antibodies was induced by the PCS vaccine than by the Gag/Env vaccine (p<0.0001). The effect of the mucosal antibody responses in protection from repeated low dose pathogenic SIVmac251 challenges is being evaluated.

Original languageEnglish (US)
Article numbere0202997
JournalPloS one
Volume13
Issue number8
DOIs
StatePublished - Aug 2018

Fingerprint

env Gene Products
gag Gene Products
Macaca fascicularis
Macaca
Antibody Formation
proteinases
Vaccines
vaccines
antibodies
Antibodies
Peptide Hydrolases
proteins
T-cells
T-lymphocytes
T-Lymphocytes
AIDS Vaccines
Sex Workers
antigens
SIV(mac) proteinase
Therapeutic Irrigation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques. / Li, Hongzhao; Hai, Yan; Lim, So Yon; Toledo, Nikki; Crecente-Campo, Jose; Schalk, Dane; Li, Lin; Omange, Robert W.; Dacoba, Tamara G.; Liu, Lewis R.; Kashem, Mohammad Abul; Wan, Yanmin; Liang, Binhua; Li, Qingsheng; Rakasz, Eva; Schultz-Darken, Nancy; Alonso, Maria J.; Plummer, Francis A.; Whitney, James B.; Luo, Ma.

In: PloS one, Vol. 13, No. 8, e0202997, 08.2018.

Research output: Contribution to journalArticle

Li, H, Hai, Y, Lim, SY, Toledo, N, Crecente-Campo, J, Schalk, D, Li, L, Omange, RW, Dacoba, TG, Liu, LR, Kashem, MA, Wan, Y, Liang, B, Li, Q, Rakasz, E, Schultz-Darken, N, Alonso, MJ, Plummer, FA, Whitney, JB & Luo, M 2018, 'Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques', PloS one, vol. 13, no. 8, e0202997. https://doi.org/10.1371/journal.pone.0202997
Li, Hongzhao ; Hai, Yan ; Lim, So Yon ; Toledo, Nikki ; Crecente-Campo, Jose ; Schalk, Dane ; Li, Lin ; Omange, Robert W. ; Dacoba, Tamara G. ; Liu, Lewis R. ; Kashem, Mohammad Abul ; Wan, Yanmin ; Liang, Binhua ; Li, Qingsheng ; Rakasz, Eva ; Schultz-Darken, Nancy ; Alonso, Maria J. ; Plummer, Francis A. ; Whitney, James B. ; Luo, Ma. / Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques. In: PloS one. 2018 ; Vol. 13, No. 8.
@article{93074fb44e0c4edd9568b08ef9560ff5,
title = "Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques",
abstract = "HIV mutates rapidly and infects CD4+ T cells, especially when they are activated. A vaccine targeting conserved, essential viral elements while limiting CD4+ T cell activation could be effective. Learning from natural immunity observed in a group of highly HIV-1 exposed seronegative Kenyan female sex workers, we are testing a novel candidate HIV vaccine targeting the 12 viral protease cleavage sites (PCSs) (the PCS vaccine), in comparison with a vaccine targeting full-length Gag and Env (the Gag/Env vaccine) in a Mauritian cynomolgus macaque/SIV model. In this study we evaluated these vaccines for induction of mucosal antibodies to SIV immunogens at the female genital tract. Bio-Plex and Western blot analyses of cervicovaginal lavage samples showed that both the PCS and Gag/Env vaccines can elicit mucosal IgG antibody responses to SIV immunogens. Significantly higher increase of anti-PCS antibodies was induced by the PCS vaccine than by the Gag/Env vaccine (p<0.0001). The effect of the mucosal antibody responses in protection from repeated low dose pathogenic SIVmac251 challenges is being evaluated.",
author = "Hongzhao Li and Yan Hai and Lim, {So Yon} and Nikki Toledo and Jose Crecente-Campo and Dane Schalk and Lin Li and Omange, {Robert W.} and Dacoba, {Tamara G.} and Liu, {Lewis R.} and Kashem, {Mohammad Abul} and Yanmin Wan and Binhua Liang and Qingsheng Li and Eva Rakasz and Nancy Schultz-Darken and Alonso, {Maria J.} and Plummer, {Francis A.} and Whitney, {James B.} and Ma Luo",
year = "2018",
month = "8",
doi = "10.1371/journal.pone.0202997",
language = "English (US)",
volume = "13",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques

AU - Li, Hongzhao

AU - Hai, Yan

AU - Lim, So Yon

AU - Toledo, Nikki

AU - Crecente-Campo, Jose

AU - Schalk, Dane

AU - Li, Lin

AU - Omange, Robert W.

AU - Dacoba, Tamara G.

AU - Liu, Lewis R.

AU - Kashem, Mohammad Abul

AU - Wan, Yanmin

AU - Liang, Binhua

AU - Li, Qingsheng

AU - Rakasz, Eva

AU - Schultz-Darken, Nancy

AU - Alonso, Maria J.

AU - Plummer, Francis A.

AU - Whitney, James B.

AU - Luo, Ma

PY - 2018/8

Y1 - 2018/8

N2 - HIV mutates rapidly and infects CD4+ T cells, especially when they are activated. A vaccine targeting conserved, essential viral elements while limiting CD4+ T cell activation could be effective. Learning from natural immunity observed in a group of highly HIV-1 exposed seronegative Kenyan female sex workers, we are testing a novel candidate HIV vaccine targeting the 12 viral protease cleavage sites (PCSs) (the PCS vaccine), in comparison with a vaccine targeting full-length Gag and Env (the Gag/Env vaccine) in a Mauritian cynomolgus macaque/SIV model. In this study we evaluated these vaccines for induction of mucosal antibodies to SIV immunogens at the female genital tract. Bio-Plex and Western blot analyses of cervicovaginal lavage samples showed that both the PCS and Gag/Env vaccines can elicit mucosal IgG antibody responses to SIV immunogens. Significantly higher increase of anti-PCS antibodies was induced by the PCS vaccine than by the Gag/Env vaccine (p<0.0001). The effect of the mucosal antibody responses in protection from repeated low dose pathogenic SIVmac251 challenges is being evaluated.

AB - HIV mutates rapidly and infects CD4+ T cells, especially when they are activated. A vaccine targeting conserved, essential viral elements while limiting CD4+ T cell activation could be effective. Learning from natural immunity observed in a group of highly HIV-1 exposed seronegative Kenyan female sex workers, we are testing a novel candidate HIV vaccine targeting the 12 viral protease cleavage sites (PCSs) (the PCS vaccine), in comparison with a vaccine targeting full-length Gag and Env (the Gag/Env vaccine) in a Mauritian cynomolgus macaque/SIV model. In this study we evaluated these vaccines for induction of mucosal antibodies to SIV immunogens at the female genital tract. Bio-Plex and Western blot analyses of cervicovaginal lavage samples showed that both the PCS and Gag/Env vaccines can elicit mucosal IgG antibody responses to SIV immunogens. Significantly higher increase of anti-PCS antibodies was induced by the PCS vaccine than by the Gag/Env vaccine (p<0.0001). The effect of the mucosal antibody responses in protection from repeated low dose pathogenic SIVmac251 challenges is being evaluated.

UR - http://www.scopus.com/inward/record.url?scp=85052592475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052592475&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0202997

DO - 10.1371/journal.pone.0202997

M3 - Article

C2 - 30153293

AN - SCOPUS:85052592475

VL - 13

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e0202997

ER -